期刊文献+

强化他汀治疗的种族差异——中国人适合强化他汀治疗吗? 被引量:5

Racial Differences of Intensive Statin Therapy:Is Intensive Statin Therapy Proper for Chinese People?
下载PDF
导出
摘要 他汀类药物在冠心病的治疗中的地位已得到广泛认可,强化他汀治疗也已得到肯定的疗效。但强化他汀治疗在不同人种间是否存在差异,对中国人是否适合尚属未知。在此从他汀类药物代谢的种族差异、他汀类药物在亚洲人群中的药动学及临床研究证据、中国人与欧美人群的血脂异常现状的比较等方面进行阐述。得出结论:他汀类药物的代谢存在种族差异,应根据中国人群的他汀类药物代谢的特点和血脂异常的特点,在血脂达标的前提下采用较小剂量的他汀治疗。 The effect of statin therapy as well as intensive statin therapy in the coronary heart disease is widely recognized.However,it is still unknown if there are differences between various races of intensive statin therapy and if intensive statin therapy is proper for Chinese people.Here is to present race differences of statins metabolism,pharmacokinetics and clinical research proof of statins in Asians and comparison of abnormality of blood lipid between Chinese and occidental people.A conclusion is drawn that there are racial differences of statins metabolism.It is necessary for Chinese people to take a smaller dose of statins in the premise of appropriate blood lipid level.
出处 《医学综述》 2012年第4期591-593,共3页 Medical Recapitulate
关键词 强化他汀 种族差异 中国人 Intensive statin therapy Racial differences Chinese people
  • 相关文献

参考文献15

  • 1Arca M,Gaspardone A.Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events[J].Drugs,2007,67(Suppl 1):29-42. 被引量:1
  • 2Liao JK.Safety and efficacy of statins in Asians[J].Am J Cardiol FEB,2007,99(3):410-413. 被引量:1
  • 3韦侃侃,贾敏,付强,高远,杨万雷,张莉蓉.影响他汀类药物降脂治疗的相关基因的多态性及其与高脂血症的关系[J].中国新药与临床杂志,2008,27(8):570-575. 被引量:13
  • 4Lee E,Ryan S,Birmingham B,et al.Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment[J].Clin Pharmacol Ther,2005,78(4):330-341. 被引量:1
  • 5田蕾,蒋娟娟,黄一玲,刘红,韩璐璐,许莉,李一石.LC-MS/MS测定尿样瑞舒伐他汀浓度及人体药动学研究[J].中国药学杂志,2007,42(15):1174-1177. 被引量:3
  • 6Chiang CE,Huang SS,Sung SH.Efficacy and safety of rosuvastatin in Taiwan Residents patients[J].J Chin Med Assoc,2008,71(3):113-118. 被引量:1
  • 7Koba S,Sasaki J.Treatment of hyperlipidemia from Japanese evidence[J].J Atheroscler Thromb,2006,13(6):267-280. 被引量:1
  • 8Sakamoto T,Ogawa H."Just make it lower" is an alternative strategy of lipid-lowering therapy with statins in Japanese patients:LDL-cholesterol:the lower,the better; is it true for Asians?(Con)[J].Circ J,2010,74(8):1731-1741. 被引量:1
  • 9Miyauchi K,Daida H.Clinical significance of intensive lipid-lowering therapy using statins in patients with coronary artery disease:LDL-cholesterol:the lower,the better; is it true for Asians?(Pro)[J].Circ J,2010,74(8):1718-1730. 被引量:1
  • 10Garmendia F,Brown AS,Reiber I,et al.Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease(the GOALLS study)[J].Curr Med Res Opin,2000,16(3):208-219. 被引量:1

二级参考文献47

  • 1胡永芳,周宏灏.CYP3A4,CYP3A5和MDR1基因多态性对环孢素处置的影响[J].中国药理学通报,2005,21(3):257-261. 被引量:34
  • 2中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5223
  • 3The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量:126
  • 4武阳丰,赵冬,周北凡,王薇,李贤,刘静,李莹,孙佳艺,赵连成,吴兆苏,诸骏仁.中国成人血脂异常诊断和危险分层方案的研究[J].中华心血管病杂志,2007,35(5):428-433. 被引量:175
  • 5van SCHAIK RH, van der HEIDEN IP, van den ANKER JN, et al. CYP3A5 variant allele frequencies in Dutch Caucasians [J]. Clin Chem, 2002, 48(10) : 1668-1671. 被引量:1
  • 6HOFFMEYER S, BURK O, von RICHTER O, et al. Functional polymorphism of the human multidrug-resistance gene : multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo [J]. Proc Natl Acad Sci USA, 2000, 97(7) : 3473-3478. 被引量:1
  • 7TIRONA RG, LEAKE BF, MERINO G, et al. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European-and African- Americans[J]. J Biol Chem, 2001, 276(38): 35669-35675. 被引量:1
  • 8LEE E, RYAN S, BIRMINGHAM B, et al. Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment [J]. Clin Pharmacol Ther, 2005, 78(4): 330-341. 被引量:1
  • 9COUTURE P, OTVOS JD, CUPPLES LA, et al. Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study[J]. J Lipid Res, 1999, 40(10) : 1883-1889. 被引量:1
  • 10MIWA K, INAZU A, KOBAYASHI J, et al. ATP-binding cassette transporter G8 M429V polymorphism as a novel genetic marker of higher cholesterol absorption in hypercholesterolaemic Japanese subjects[J]. Clin Sci(Lond), 2005, 109(2): 183-188. 被引量:1

共引文献146

同被引文献58

  • 1王永彬,王伟.辛伐他汀对COPD患者细胞凋亡和炎症因子的干预作用[J].山东大学学报(医学版),2009,47(8):75-78. 被引量:2
  • 2Danielle Ní Chróinín,Kjell Asplund,Signild ?sberg,Elizabeth Callaly,Elisa Cuadrado-Godia,Exuperio Díez-Tejedor,Mario Di Napoli,Stefan T. Engelter,Karen L. Furie,Sotirios Giannopoulos,Antonio M. Gotto,Niamh Hannon,Fredrik Jonsson,Moira K. Kapral,Joan Martí-Fàbregas,Patricia Martínez-Sánchez,Haralampos J. Milionis,Joan Montaner,Antonio Muscari,Slaven Pikija,Jeffrey Probstfield,Natalia S. Rost,Amanda G. Thrift,Konstantinos Vemmos,Peter J. Kelly.Statin Therapy and Outcome After Ischemic Stroke: Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials[J].Stroke.2013(2) 被引量:1
  • 3Clarissa Vasconcelos de Oliveira,Vinícius Rafael Funck,Letícia Meier Pereira,Jéssica Grigoletto,Leonardo Magno Rambo,Leandro Rodrigo Ribeiro,Luiz Fernando Freire Royes,Ana Flávia Furian,Mauro Schneider Oliveira.Atorvastatin withdrawal elicits oxidative/nitrosative damage in the rat cerebral cortex[J].Pharmacological Research.2013 被引量:1
  • 4Alejandro Forteza,Jose G. Romano,Iszet Campo-Bustillo,Nelly Campo,Diogo C. Haussen,Jose Gutierrez,Sebastian Koch.High-Dose Atorvastatin Enhances Impaired Cerebral Vasomotor Reactivity[J].Journal of Stroke and Cerebrovascular Diseases.2012(6) 被引量:1
  • 5Majaz Moonis.High-Dose Statins Should Be Used in All Acute Ischemic Strokes[J].Stroke.2012(7) 被引量:1
  • 6Alexander C. Flint,Hooman Kamel,Babak B. Navi,Vivek A. Rao,Bonnie S. Faigeles,Carol Conell,Jeff G. Klingman,Stephen Sidney,Nancy K. Hills,Michael Sorel,Sean P. Cullen,S. Claiborne Johnston.Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival[J].Stroke.2012(1) 被引量:1
  • 7Manuel Cappellari,Cristina Deluca,Michele Tinazzi,Giampaolo Tomelleri,Monica Carletti,Antonio Fiaschi,Paolo Bovi,Giuseppe Moretto.Does statin in the acute phase of ischemic stroke improve outcome after intravenous thrombolysis? A retrospective study[J].Journal of the Neurological Sciences.2011(1) 被引量:1
  • 8Alessandro Biffi,William J. Devan,Christopher D. Anderson,Lynelle Cortellini,Karen L. Furie,Jonathan Rosand,Natalia S. Rost.Statin Treatment and Functional Outcome After Ischemic Stroke: Case–Control and Meta-Analysis[J].Stroke A Journal of Cerebral Circulation.2011(5) 被引量:1
  • 9A. Biffi,W.J. Devan,C.D. Anderson,A.M. Ayres,K. Schwab,L. Cortellini,A. Viswanathan,N.S. Rost,E.E. Smith,J.N. Goldstein,S.M. Greenberg,J. Rosand.Statin use and outcome after intracerebral hemorrhage: Case-control study and meta-analysis[J].Neurology.2011(18) 被引量:1
  • 10Danielle Ní Chróinín,Elizabeth L. Callaly,Joseph Duggan,áine Merwick,Niamh Hannon,órla Sheehan,Michael Marnane,Gillian Horgan,Emma B. Williams,Dawn Harris,Lorraine Kyne,Patricia M.E. McCormack,Joan Moroney,Tim Grant,David Williams,Leslie Daly,Peter J. Kelly.Association Between Acute Statin Therapy, Survival, and Improved Functional Outcome After Ischemic Stroke: The North Dublin Population Stroke Study[J].Stroke.2011(4) 被引量:1

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部